
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2015-010197corr110.1136/bmjopen-2015-010197corr1Correction1506Correction 2017 13 2 2017 7 2 e010197corr1Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/2017This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
==== Body
Conget I, Mauricio D, Ortega R on behalf of the CHADIG Study investigators, et al. Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain. BMJ Open 2016;6:e010197. doi: 10.1136/bmjopen-2015-010197

Four of the Collaborator names were written incorrectly. ‘Francisco Merino Torres’ should have been written ‘Juan Francisco Merino-Torres’, ‘Fernando Gómez Peralta’ as ‘Fernando Gomez-Peralta’, ‘Diego Bellido Guerrero’ as ‘Diego Bellido’ and ‘Miguel Ángel Mangas’ as ‘Miguel Angel Mangas-Cruz’.
